HIPEC with CRS versus cytoreductive surgery (CRS) for the gastric cancer metastasis to peritoneum

被引：4
|
作者：
Chen, Zhuming [1 ]
Ali, Muhammad [2 ,3 ]
Kai, Zhe [1 ]
Wang, Yang [2 ,3 ]
Wang, Chaohui [1 ]
机构：
[1] Anhui Med Univ, Dept Gen Surg, Anqing Peoples Hosp 1, Hefei, Peoples R China
[2] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Yangzhou 225001, Jiangsu, Peoples R China
[3] Yangzhou Univ, Med Coll, Yangzhou 225001, Jiangsu, Peoples R China
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2023年 / 25卷 / 04期
关键词：
Hyperthermic intraperitoneal chemotherapy; Peritoneal metastasis; Gastrectomy and gastric cancer; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CARCINOMATOSIS;
D O I：
10.1007/s12094-022-03004-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background Peritoneal metastases (PM) have a poor prognosis in gastric cancer (GC). Cytoreductive surgery (CRS) gives favorable outcomes, but the influence of hyperthermic intraperitoneal chemotherapy (HIPEC) remains contentious. We designed to distinguish results between CRS versus HIPEC-CRS in patients with peritoneal metastases from gastric cancer. Materials and methods PubMed, Scopus, Embase and Cochrane library accessed to collect data and language is restricted to English. RevMan 5.4 was used to perform statistical analysis. The outcomes for categorical variables are mentioned in the risk ratio. Results Ten trials involving 1367 patients in which 707 were CRS-HIPEC, while 660 CRS. We got significant results in 3rd year survival (P < 0.05), while 1st and 5th years are not statistically significant P > 0.05. Conclusion To compare with CRS, CRS-HIPEC has improved survival rate in deprived of further morbidity or mortality.
引用
收藏
页码：1011 / 1016
页数：6
相关论文
共 50 条
  • [1] The Landmark Series: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for Treatment of Gastric Cancer Metastatic to Peritoneum
    Dineen, Sean P.
    Pimiento, Jose M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4130 - 4137
  • [2] The Landmark Series: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for Treatment of Gastric Cancer Metastatic to Peritoneum
    Sean P. Dineen
    Jose M. Pimiento
    Annals of Surgical Oncology, 2021, 28 : 4130 - 4137
  • [3] Efficacy of Cytoreductive Surgery (CRS) plus HIPEC in Gastric Cancer with Peritoneal Metastasis: Systematic Review and Meta-Analysis
    Langellotti, Lodovica
    Fiorillo, Claudio
    D'Annibale, Giorgio
    Panza, Edoardo
    Pacelli, Fabio
    Alfieri, Sergio
    Di Giorgio, Andrea
    Santullo, Francesco
    CANCERS, 2024, 16 (10)
  • [4] Cytoreductive surgery (CRS) and HIPEC in recurrent platinum resistant ovarian cancer
    Brown, C. K.
    Williams, S.
    McNutt, L.
    Beilick, S.
    Flynn, R.
    Litvack, D.
    Huss, H.
    Nair, A. R.
    Del Priore, G.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 114 - 114
  • [5] Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal carcinomatosis arising from gastric cancer
    Piso, P.
    Glockzin, G.
    Schlitt, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [6] Cytoreductive Reductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Ovarian Cancer
    Tan, G.
    Chia, C.
    Teo, M.
    Soo, K. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 839 - 839
  • [7] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma
    Tan, Grace H. C.
    Cheung, Michelle
    Chanyaputhipong, Jendana
    Soo, Khee Chee
    Teo, Melissa C. C.
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2013, 42 (06) : 291 - 296
  • [8] CRS and HIPEC for patients with peritoneal metastases of gastric cancer
    Brandl, A.
    Raue, W.
    Reich, J.
    Pratschke, J.
    Raue, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 83 - 83
  • [9] Anastomotic leakage after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer
    Feenstra, Tim Michael
    Verberne, Charlotte Julia
    Kok, Niels F. M.
    Aalbers, Arend Geert Johan
    EJSO, 2022, 48 (12): : 2460 - 2466
  • [10] Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Acs, Miklos
    Babucke, Maximilian
    Jusufi, Maximilian
    Kaposztas, Zsolt
    Slowik, Przemyslaw
    Hornung, Matthias
    Schlitt, Hans J.
    Panczel, Ivan
    Hevesi, Judit
    Herzberg, Jonas
    Strate, Tim
    Piso, Pompiliu
    INNOVATIVE SURGICAL SCIENCES, 2024, 9 (01): : 3 - 15
12345